Skip to main content

and
  1. No Access

    Article

    Residual platelet reactivity, thrombus burden and myocardial reperfusion in patients treated by PCI after successful pre-hospital fibrinolysis compared to primary PCI

    We compared residual platelet reactivity and post PCI atherothrombotic burden using OFDI in patients successfully treated by primary PCI versus pharmacoinvasive approach (PI) defined as PCI after successful pr...

    Vincent Roule, Lin Schwob, Clément Briet in Journal of Thrombosis and Thrombolysis (2020)

  2. Article

    Open Access

    Systematic review and meta-analysis of the prognostic impact of cancer among patients with acute coronary syndrome and/or percutaneous coronary intervention

    Patients with cancer admitted for an acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI) represent a growing and high-risk population. The influence of co-existing cancer on mortality...

    Vincent Roule, Laurine Verdier, Katrien Blanchart in BMC Cardiovascular Disorders (2020)

  3. No Access

    Article

    Plaque erosion versus rupture characterization by optical frequency domain imaging before and after coronary stenting following successful fibrinolysis for ST-segment elevation myocardial infarction

    Intracoronary thrombus burden affects the quality of myocardial reperfusion in the setting of ST-elevation myocardial infarction (STEMI). We aimed to study the characteristics of the plaque and thrombus assess...

    Vincent Roule, Clément Briet, Adrien Lemaitre, Pierre Ardouin in Heart and Vessels (2019)

  4. Article

    Open Access

    Prehospital fibrinolysis versus primary percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized controlled trials

    Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion strategy in patients with ST-elevation myocardial infarction (STEMI), but its benefit over prehospital fibrinolysis (FL) is not cl...

    Vincent Roule, Pierre Ardouin, Katrien Blanchart, Adrien Lemaitre in Critical Care (2016)

  5. No Access

    Article

    Oral diclofenac combined with intra-portal pirarubicin: increased efficacy on liver VX2 tumour and hepatotoxicity in rabbits

    VX2 is a carcinoma established in rabbits and producing an autocrine growth factor, prostaglandin E2. Pirarubicin is a potent anti-VX2 agent. We investigated whether the oral intake of enprostil—a synthetic prost...

    Bruno Donatini, Caroline Bognel in Journal of Cancer Research and Clinical On… (1994)